CHRISTINE BROCIOUS: Open Payments
NPI 1194277798 · NEW PARIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 63 payments from 19 companies in 2025. Trend: 2023 $1,106 · 2024 $1,019 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $351 |
| Viatris Specialty LLC | 5 | $92 |
| Lilly USA, LLC | 5 | $88 |
| Ardelyx, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Novo Nordisk Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
Products named: VRAYLAR, QULIPTA, YUPELRI, IBSRELA, ELIQUIS, GEMTESA, MOUNJARO, CREON.
Industry payments across PA — which companies pay providers there.
